首页|曲美他嗪联合体外反搏在老年慢性心力衰竭患者中的应用效果

曲美他嗪联合体外反搏在老年慢性心力衰竭患者中的应用效果

扫码查看
目的 探讨曲美他嗪联合体外反搏在老年慢性心力衰竭患者中的应用效果.方法 选取 2022 年 4 月—2023 年 4 月该院收治的 112 例老年慢性心力衰竭患者为研究对象,按随机数字表法将其分为对照组与观察组,各56 例.对照组使用盐酸曲美他嗪片治疗,观察组在对照组基础上联合体外反搏治疗.比较两组临床疗效、心功能指标、血管内皮功能、生命质量.结果 治疗7周后,观察组治疗总有效率为96.43%,高于对照组的76.79%,差异有统计学意义(P<0.05).观察组左室收缩末期内径、左室舒张末期内径均短于对照组,左室射血分数高于对照组,组间差异有统计学意义(P<0.05).观察组肱动脉非内皮依赖性舒张功能、肱动脉内皮依赖性舒张功能均高于对照组,人内皮素-1 低于对照组,组间差异有统计学意义(P<0.05).观察组Lee氏心力衰竭评分及明尼苏达州心功能不全生命质量评分均低于对照组,组间差异有统计学意义(P<0.05).结论 曲美他嗪联合体外反搏应用于老年慢性心力衰竭中,具有显著疗效,可改善患者心功能、血管内皮功能,有利于其生命质量的提升,且具有安全性.
Effect of Trimetazidine Combined with External Counterpulsation in Elderly Patients with Chronic Heart Failure
Objective To investigate the effect of trimetazidine combined with external counterpulsation in elderly patients with chronic heart failure.Methods A total of 112 elderly patients with chronic heart failure admitted to the hospital from April 2022 to April 2023 were selected as the study objects,and divided into a control group and an observation group according to random number table method,with 56 cases in each group.The control group was treated with trimetazidine hydrochloride tablets,and the observation group was combined with external counterpulsation therapy on the basis of the control group.The clinical efficacy,cardiac function index,vascular endothelial function and quality of life between the two groups were compared.Results After 7 weeks of treatment,the total effective rate of the observation group was 96.43%,which was higher than 76.79%of the control group,the difference was statistically significant(P<0.05).Left ventricular end-systolic diameter and left ventricular end-diastolic diameter in the observation group were shorter than those in control group,and left ventricular ejection fraction was higher than that in control group,and the differences were statistically significant(P<0.05).The NMD and FMD of brachial artery in observation group were higher than those in control group,and human endothelin-1 was lower than that in control group,and the differences were statistically significant(P<0.05).Lee's heart failure scores and Minnesota Heart Failure Quality of Life scale scores in the observation group were lower than those in the control group,and the differences between groups were statistically significant(P<0.05).Conclusion The application of trimetazidine combined with external counterpulsation in elderly patients with chronic heart failure has significant efficacy,can improve the cardiac function and vascular endothelial function of patients,and is conducive to the improvement of their quality of life,and has safety.

Chronic heart failureAgedTrimetazidineExternal counterpulsationCardiac functionVascular endothelial function

王薇、陈梅、孟珍芝

展开 >

济宁医学院附属滕州市中心人民医院心血管内科,山东枣庄 277500

慢性心力衰竭 老年 曲美他嗪 体外反搏 心功能 血管内皮功能

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(5)
  • 8